Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.180
+0.030 (2.61%)
May 5, 2025, 4:00 PM EDT - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $48.48 million as of May 5, 2025. Its market cap has decreased by -35.76% in one year.
Market Cap
48.48M
Enterprise Value
32.25M
1-Year Change
-35.76%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $48.48M, a decrease of -70.23%. That is a compound annual growth rate of -26.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 47.25M | 8.45% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |